COMMUNIQUÉS West-GlobeNewswire

Fagron NV: Disclosure of received notifications
26/06/2018
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 26 June 2018 - 6:30am (CET) Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron [...]
Immuron Announces Board Appointment
26/06/2018
MELBOURNE, Australia, June 25, 2018 (GLOBE NEWSWIRE) -- Australian biopharmaceutical company Immuron Limited (ASX:IMC), is pleased to announce the appointment of New York based Mr. Richard Jay Berman to serve as a [...]
Zomedica Joins Russell 3000™ and Russell Microcap® Indexes
25/06/2018
ANN ARBOR, Mich., June 25, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic and pharmaceutical company, today announced that [...]
Wave Life Sciences to Present at Parent Project Muscular Dystrophy Annual Conference
25/06/2018
CAMBRIDGE, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases [...]
UPDATE: Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
25/06/2018
ARLINGTON, Va., June 25, 2018 (GLOBE NEWSWIRE) -- Today IMV, part of the Science and Medicine Group, and the leading market research and business intelligence provider to the Imaging industry, announced the category [...]
Real-World Data Supports Association Between High Triglyceride Levels and Increased Cardiovascular Events and Healthcare Costs in People with Diabetes Mellitus
25/06/2018
Data Underscores the Need for the REDUCE-IT™ Cardiovascular Outcomes Study BEDMINSTER, N.J. and DUBLIN, Ireland, June 25, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company [...]
AVROBIO, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Overallotment Option
25/06/2018
CAMBRIDGE, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc . (NASDAQ:AVRO) (the “Company”), a Phase 2 clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral-based gene [...]
Eloxx Expands Leadership Team with Two Global Pharmaceutical Executives to Accelerate Growth
25/06/2018
Dr. Greg Williams appointed Chief Operating Officer David P. Snow appointed Chief Business Officer Eloxx added to the Russell 2000® Index effective June 25, 2018 WALTHAM, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Eloxx [...]
Actinium Provides Update from Society of Nuclear Medicine and Molecular Imaging Annual Meeting
25/06/2018
Two Nuclear Medicine focused advisory boards have been formed to provide expertise and strategic guidance to Actinium Meeting with Iomab-B and Actimab investigators to be held to provide trial updates and discuss [...]
Sunesis Pharmaceuticals Enters into $15.5 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
25/06/2018
SOUTH SAN FRANCISCO, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it has entered into a Common Shares Purchase Agreement (the “Agreement”) of up to $15.5 [...]
Prothena Announces Appointment of Tran B. Nguyen as Chief Operating Officer
25/06/2018
DUBLIN, Ireland, June 25, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage biotechnology company focused on the discovery and development of novel therapies in the neuroscience category [...]
Opiant Pharmaceuticals Announces Receipt of First Tranche from National Institutes of Health Grant for Development of OPNT003, Intranasal Nalmefene, for Treatment of Opioid Overdose
25/06/2018
Initial $500,000 to be Utilized to Advance the Development of OPNT003 SANTA MONICA, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company [...]
NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock
25/06/2018
Closes on $30 Million Extension to Senior Credit Facility FT. MYERS, Fla., June 25, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ:NEO) (the “Company”), a leading provider of cancer-focused genetic testing services [...]
Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
25/06/2018
BOSTON, June 25, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]
Biogen to Report Second Quarter 2018 Financial Results on July 24, 2018
25/06/2018
CAMBRIDGE, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Biogen Inc . (Nasdaq:BIIB) today announced it will report second quarter 2018 financial results on Tuesday, July 24, 2018, before the financial markets open. Following [...]
The Alliance for Regenerative Medicine Submits Comments to CMS Regarding Medicare's Hospital Inpatient Prospective Payment Systems New Technology Add-on Payment Program
25/06/2018
WASHINGTON, D.C., , June 25, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector [...]
GW Pharmaceuticals plc and its U.S. Subsidiary Greenwich Biosciences Announce FDA Approval of EPIDIOLEX® (cannabidiol) oral solution – the First Plant-derived Cannabinoid Prescription Medicine
25/06/2018
Approval for seizures associated with Lennox-Gastaut Syndrome or Dravet Syndrome, two rare, severe childhood-onset epilepsies LONDON and CARLSBAD, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq [...]
CohBar Presents Preclinical Data on Mechanism of Action for its Lead Candidate, CB4211, at American Diabetes Association 78th Scientific Sessions
25/06/2018
MENLO PARK, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR), an innovative biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today [...]
Dynavax Presents Analysis of Data for Participants Aged 60 to 70 with Diabetes from its Phase 3 Trial of HEPLISAV-B®
25/06/2018
In a Post-Hoc Analysis of Elderly Diabetic Patients, HEPLISAV-B was Well-Tolerated and Induced Higher Rates of Seroprotection than Engerix-B Data Presented at 2018 American Diabetes Association Annual Meeting BERKELEY, [...]

Pages